The purpose of the study is to assess the safety and efficacy of hybrid revascularization in comparison with coronary artery bypass grafting among patients with multivessel coronary artery disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
First stage: implantation of the internal mammary artery into LAD in MIDCAB/TECAB procedure Second stage: PCI with drug eluting stents in other coronary arteries qualified for revascularization within 36 hours after surgery
Coronary artery bypass grafting with sternotomy on or off the pump at discretion of the operator.
Department of Cardiosurgery and Transplatology, Silesian Medical University, Silesian Center for Heart Disease
Zabrze, Poland
Third Department of Cardiology, Silesian Medical University, Silesian Center for Heart Disease
Zabrze, Poland
Possibility defined by means of (1) a % of pts with complete hybrid procedure according to study protocol, and (2) a % of conversion to standard CABG. Safety defined as a occurrence of MACE such as death, MI, stroke, TVR, or major bleeding.
Time frame: 1 year
Postprocedure and follow up angiographic measurements as patency of grafts and restenosis in revascularized segments
Time frame: 1 year
Assessment of quality of life of alive study participants according to SF-36 Health Survey version 2
Time frame: 1 year
Cost-effectiveness defined as a cost of revascularization procedure and costs of hospitalizations in both groups.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.